Long-lasting and fast methylglyoxal-scavenging peptide CycK(Myr)R4E alleviates chronic pain in type 2 diabetic mice
Authors:
Open Access
- 12 August 2025
- journal article
- basic science
- Published by Wolters Kluwer Health in Pain Reports
- Vol. 10 (5) , e1312
Abstract
Introduction: Pathological levels of methylglyoxal (MG), a reactive dicarbonyl product of glucose, contribute to major neurological complications associated with type II diabetes, including chronic neuropathic pain. Strategies to target elevated MG have included small molecule MG scavengers, but scavenger deficiencies in proteolytic stability and onset of scavenging activity have precluded clinical translation. To address this gap, we developed a long-lasting and highly reactive cyclic peptide CycK(Myr)R4E, and here evaluated its antihyperalgesic efficacy in the db/db mouse model of type II diabetes painful diabetic neuropathy. Objectives: To test the hypothesis that CycK(Myr)R4E can reduce behavioral and molecular signs of painful diabetic neuropathy. Methods: We assessed heat hypersensitivity as an index of hyperalgesia, and touch-evoked expression of phosphorylated extracellular signal–regulated kinase as a measure of neuronal activity in spinal cord dorsal horn. Results: We report that a single systemic injection of CycK(Myr)R4E (3 mg/kg) reversed heat hypersensitivity. Repeated systemic injection of CycK(Myr)R4E (0.125 mg/kg, 3 times per week, 6–12 weeks of age) prevented heat hypersensitivity and reduced stimulus-evoked phosphorylated extracellular signal–regulated kinase. Conclusion: These studies promote CycK(Myr)R4E as the most promising MG scavenger for the prevention and treatment of hyperalgesia in type 2 diabetic neuropathic pain.Keywords
This publication has 63 references indexed in Scilit:
- Diabetes-Induced Mechanical Hyperalgesia Involves Spinal Mitogen-Activated Protein Kinase Activation in Neurons and Microglia via N-Methyl-D-aspartate-Dependent MechanismsMolecular Pharmacology, 2006
- Susceptibility to Diabetic Nephropathy Is Related to Dicarbonyl and Oxidative StressDiabetes, 2005
- Metformin inhibition of glycation processesDiabetes & Metabolism, 2003
- A Post-Amadori Inhibitor Pyridoxamine Also Inhibits Chemical Modification of Proteins by Scavenging Carbonyl Intermediates of Carbohydrate and Lipid DegradationJournal of Biological Chemistry, 2002
- Nociceptive-specific activation of ERK in spinal neurons contributes to pain hypersensitivityNature Neuroscience, 1999
- Design and Baseline Characteristics for the Aminoguanidine Clinical Trial in Overt Type 2 Diabetic Nephropathy (ACTION II)Controlled Clinical Trials, 1999
- Metformin reduces systemic methylglyoxal levels in type 2 diabetes.Diabetes, 1999
- L‐arginine‐induced vasodilation in healthy humans:pharmacokinetic–pharmacodynamic relationshipBritish Journal of Clinical Pharmacology, 1998
- Ethical guidelines for investigations of experimental pain in conscious animalsPain, 1983
- Obese and diabetes: Two mutant genes causing diabetes-obesity syndromes in miceDiabetologia, 1978